Home LiteratureArticle Details
PMID: 12370353 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 169 ·No. 8 ·2002-10-15 ·Pages 4230-6

Wilcox RA, Tamada K, Strome SE, Chen L

Abstract

NK cells possess both effector and regulatory activities that may be important during the antitumor immune response. In fact, the generation of antitumor immunity by the administration of an agonistic mAb against CD137 is NK cell-dependent. In this study, we report that NK cells could be induced by IL-2 and IL-15 to express CD137 and ligation of CD137-stimulated NK cell proliferation and IFN-gamma secretion, but not their cytolytic activity. Importantly, CD137-stimulated NK cells promoted the expansion of activated T cells in vitro, demonstrating immunoregulatory or "helper" activity for CD8(+)CTL. Furthermore, tumor-specific CTL activity against P815 tumor Ags was abrogated following anti-CD137 treatment in NK-depleted mice. We further demonstrate that CD137-stimulated helper NK cells expressed the high-affinity IL-2R and were hyperresponsive to IL-2. Taken together with previous findings that CD137 is a critical receptor for costimulation of T cells, our findings suggest that CD137 is a stimulatory receptor for NK cells involved in the crosstalk between innate and adaptive immunity.

MeSH Terms
Adjuvants, Immunologic/metabolism Animals Antigens, CD Cytotoxicity, Immunologic Female Growth Substances/metabolism Injections, Intraperitoneal Injections, Subcutaneous Interleukin-2/metabolism,pharmacology Killer Cells, Natural/immunology,metabolism Leukemia L1210 Lymphocyte Subsets/immunology Mice Mice, Inbred C57BL Mice, Inbred DBA Mice, Knockout Mice, Transgenic Receptors, Interleukin-2/biosynthesis Receptors, Nerve Growth Factor/administration & dosage,biosynthesis,physiology Receptors, Tumor Necrosis Factor/administration & dosage,biosynthesis,physiology Signal Transduction/immunology Solubility T-Lymphocytes, Cytotoxic/cytology,immunology Tumor Cells, Cultured Tumor Necrosis Factor Receptor Superfamily, Member 9 Up-Regulation/immunology
Chemicals
Adjuvants, Immunologic Antigens, CD Growth Substances Interleukin-2 Receptors, Interleukin-2 Receptors, Nerve Growth Factor Receptors, Tumor Necrosis Factor Tnfrsf9 protein, mouse Tumor Necrosis Factor Receptor Superfamily, Member 9
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wilcox Ryan A
Department of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Tamada Koji
Strome Scott E
Chen Lieping
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2002-10-15
Pages
4230-6
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NCI NIH HHS · CA 79915 · United States
NCI NIH HHS · CA 87521 · United States
NIDCR NIH HHS · DE 00459 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com